THC Therapeutics, Inc. (THCT)
OTCMKTS · Delayed Price · Currency is USD
0.0056
+0.0050 (833.33%)
At close: Mar 16, 2026

THC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
000132
Market Cap Growth
-96.12%-76.42%-88.38%-68.03%83.70%-96.03%
Enterprise Value
111232
Last Close Price
0.000.000.000.030.110.07
PB Ratio
-0.01-0.01-0.03-0.28-1.11-0.86
Debt / Equity Ratio
-0.23-0.23-0.24-0.30-0.35-0.29
Net Debt / Equity Ratio
-0.23-0.23-0.24-0.30-0.23-0.27
Net Debt / EBITDA Ratio
-1.62-1.62-1.61-0.55-0.61-0.34
Net Debt / FCF Ratio
-4.78-4.78-9.26-2.26-1.44-0.80
Quick Ratio
00000.100.02
Current Ratio
0000.010.110.02
Return on Assets (ROA)
-2866.01%-2866.01%-280.77%-317.71%-207.81%-287.10%
Return on Capital Employed (ROCE)
14.30%14.30%14.90%58.00%39.50%79.70%
Earnings Yield
-2015.50%-3359.11%-377.82%-172.37%-68.42%-128.75%
FCF Yield
--758.58%-83.40%-47.54%-14.10%-39.19%
Buyback Yield / Dilution
-8.76%-8.76%1.32%-40.51%-42.95%-23.73%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.